Prevalence and factors associated with the severity of anaemia among patients on chronic haemodialysis in Lagos, Nigeria
Ann. Health Res. (Onabanjo Univ. Teach. Hosp.)
; 9(3): 190-198, 2023. tables, figures
Artigo
em Inglês
| AIM (África)
| ID: biblio-1512876
Biblioteca responsável:
CG1.1
ABSTRACT
Anaemia is a global public health problem with high mortality and morbidity. It is also a common consequence of chronic kidney disease (CKD). There is a paucity of data on the actual burden of anaemia among patients on chronic haemodialysis (CHD) in Lagos, Nigeria. Objectives:
To determine the prevalence and factors associated with the severity of anaemia among Nigerian patients undergoing chronic haemodialysis.Methods:
This was a retrospective analysis of adult patients with end-stage renal disease (ESRD) on maintenance haemodialysis at the Lagos State University Teaching Hospital, Ikeja, Lagos. The data extracted from the clinical case files included the bio-demographic and clinical parameters, including the treatment modalities.Results:
A total of 92 patients comprising 69 (75%) males and 23 (25.0%) females with the overall mean age of 48.2±14.0 years were included. Hypertension was the commonest aetiology of CKD and the average duration of haemodialysis was 16.6 months. The commonest access route for haemodialysis was a central line while 96.7% and 81.5% received erythropoietin and intravenous iron sucrose respectively. Seventy-three (79.3%) patients have had intra-dialysis blood transfusions in the past. Mild, moderate, and severe anaemia were recorded in 17%, 67%, and 16% respectively. The use of erythropoietin, iron sucrose, and increased frequency of blood transfusions correlated with the severity of anaemia.Conclusion:
Anaemia is highly prevalent among patients with CKD on chronic haemodialysis. Increased frequency of blood transfusions, inadequate utilization of erythropoietin, and iron sucrose administration are associated with anaemia severity.
Texto completo:
Disponível
Contexto em Saúde:
ODS3 - Meta 3.4 Reduzir as mortes prematuras devido doenças não transmissíveis
Problema de saúde:
Outras Hemoglobinopatias e Anemias Hemolíticas
Base de dados:
AIM (África)
Assunto principal:
Eritropoetina
/
Diálise Renal
/
Anemia Hemolítica
Limite:
Humanos
Idioma:
Inglês
Revista:
Ann. Health Res. (Onabanjo Univ. Teach. Hosp.)
Ano de publicação:
2023
Tipo de documento:
Artigo
Instituição/País de afiliação:
Department of Community Health and Primary Healthcare/NG
/
Department of Medicine/NG
/
School of Computing and Information, University of Pittsburgh/US